Skip to content
★ Sign in to follow
SG

Sven Göthe

Asarina Pharma AB
Total declarations
3
Company
1
▲ Purchases (3 ops.)
€44k
▼ Sales (0 ops.)
—

Latest filing published 28 May 2021 for Asarina Pharma AB, €4,933.

Filing timeline

BuySale
Sven Göthe

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Sven Göthe: trading record in brief

Sven Göthe appears in our data through filings on Asarina Pharma AB shares, published by Finansinspektionen. Between 19 September 2018 and 28 May 2021, the trades on record add up to 3 filings.

No open-market sale appears; the market trades are 3 purchases worth €44k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2021: 1 purchase and no sales on the market.

Half of the purchases are above €10k and half below.

The record was last updated on 28 May 2021 with an open-market purchase (€4,933) in Asarina Pharma AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Sven Göthe

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesAsarina Pharma AB
    49,820 SEK0FI-SE
    94,000 shares@ SEK 0.5311.2% of flowWarrantISIN SE0011641794FI:csv-76e16e83d94d7c0f6807
    Canonical exit: 26 Aug 2021 (T+90)
  • ▲
    CMC DirectorExecutivesAsarina Pharma AB
    305,000 SEK0FI-SE
    61,000 shares@ SEK 5.0074.0% of flowWarrantFI:csv-2d70a003f19186f2a036
    Canonical exit: 28 Apr 2020 (T+90)
  • ▲
    Director CMC/ManufacturingExecutivesAsarina Pharma AB
    105,000 SEK32FI-SE
    5,000 shares@ SEK 21.0026.0% of flowAktieISIN SE0011641794FI:csv-90ea15ecbc9654883dc9
    Canonical exit: 18 Dec 2018 (T+90)

3 of 3 declarations